Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

The ratio of non-tuberculosis mycobacteria and co-morbidities in our hospital in the last five years

Arzu Erturk, Melike Atasever, Fatma Irem Yesiler, Sema Canbakan, Zühal Müjgan Güler, Nermin Capan
European Respiratory Journal 2012 40: P2725; DOI:
Arzu Erturk
1Pulmonology, Atatürk Chest Disease and Chest Surgery Education Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melike Atasever
2Microbiology, Atatürk Chest Disease and Chest Surgery Education Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatma Irem Yesiler
1Pulmonology, Atatürk Chest Disease and Chest Surgery Education Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sema Canbakan
1Pulmonology, Atatürk Chest Disease and Chest Surgery Education Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zühal Müjgan Güler
1Pulmonology, Atatürk Chest Disease and Chest Surgery Education Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nermin Capan
1Pulmonology, Atatürk Chest Disease and Chest Surgery Education Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Non tuberculosis mycobacterial infections (NTM) with chronic pulmonary diseases have increased in recent years. HIV infections and other co-morbid pulmonary diseases seem to be responsible for this relation as well as improvement in diagnostic techniques. Prolonged life time in COPD and cystic fibrosis generates special risk. NTM colonisation may cause clinical infection and progression in destructive pulmonary diseases.The objective of this study is to evaluate the NTM growth ratio and clinical features of these patients.

In our laboratory, approximately 25.000 specimens are cultured yearly with classic method (Lowenstein-Jensen). In this retrospective analyse, 185 NTM (1.58 %) were identified in 11.681 tuberculosis culture positive specimens between 2004 and 2009.

Results:33 patient files were examined out of 55 patients with NTM infection. Seven patients were female, 26 were male. Fifteen patients were ≥ 65 years old and the others were < 65 years old. COPD, bronchiectasis. diabetes mellitus, malignancy, HCV infection were diagnosed in 10, 10, 6, 8 and 1 patients, respectively. Nodules, cavitary lesions and fibrosis were seen in computerised tomographies of 31 patients and in x- rays of two patients. In only 7 of 55 patient's cultures were identified as M. abscessus (2), M. szulgai(3), M. intracellulare(1), M. xenopi(1). Thirty-one patients with NTM (93.39 %) had chronic systemic or pulmonary diseases.

Conclusion: In future, the ratio of diagnosing and treatment of NTM infections in older immun- competent patients with chronic diseases are going to be increased with developing laboratory tests, CT and the awareness of togetherness of NTM infections and chronic diseases.

  • Chronic disease
  • Comorbidities
  • Infections
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The ratio of non-tuberculosis mycobacteria and co-morbidities in our hospital in the last five years
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The ratio of non-tuberculosis mycobacteria and co-morbidities in our hospital in the last five years
Arzu Erturk, Melike Atasever, Fatma Irem Yesiler, Sema Canbakan, Zühal Müjgan Güler, Nermin Capan
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2725;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The ratio of non-tuberculosis mycobacteria and co-morbidities in our hospital in the last five years
Arzu Erturk, Melike Atasever, Fatma Irem Yesiler, Sema Canbakan, Zühal Müjgan Güler, Nermin Capan
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2725;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Experience of managing TB/HIV infection in a regional UK center over a 5 year period
  • Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
  • Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD
Show more 10.2 Tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society